Hansa Biopharma AB ( ($SE:HNSA) ) has provided an update. Hansa Biopharma announced that its Phase 3 trial for the treatment of anti-glomerular ...

The first partner company is on the path to market, but the implications are clear: eXoZymes has created a scalable production engine for molecules that were previously too rare or expensive to make.

The curious minds at ColdFusion reveal how AI engineered an enzyme that eats plastic waste. How a US admiral decided to kill ...

By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...

Soil microbes remove carbon from the atmosphere and store it underground, revealing an overlooked pathway for storage in ...

India, the largest milk producer, is experiencing a rise in demand for lactose-free products due to health consciousness.

Manufacture of multiple Dyadic-origin products by Fermbox Bio, enabling efficient production and market expansion of sustainable, animal-free proteins and enzymes. Dual-Sourcing flexibility, allowing ...

Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...

Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...

PLAMseq utilizes a rapid biotinylation enzyme called TurboID, which tags nearby proteins, enabling the genomic loci and ...

What will be the next blockbuster research to emerge from Princeton’s labs? No one can say for sure, but history tells us ...

The "Malabsorption Syndrome Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Malabsorption Syndrome was valued at US$3.5 Billion in ...